MainStreet Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $461K | Sell |
1,310
-104
| -7% | -$37.1K | 0.07% | 133 |
|
|
2025
Q4 | $463K | Sell |
1,414
-411
| -23% | -$130K | 0.07% | 127 |
|
|
2025
Q3 | $515K | Buy |
1,825
+186
| +11% | +$53.9K | 0.07% | 122 |
|
|
2025
Q2 | $458K | Buy |
1,639
+50
| +3% | +$14.2K | 0.06% | 124 |
|
|
2025
Q1 | $495K | Sell |
1,589
-339
| -18% | -$100K | 0.07% | 118 |
|
|
2024
Q4 | $503K | Sell |
1,928
-11
| -0.6% | -$3.26K | 0.07% | 113 |
|
|
2024
Q3 | $625K | Sell |
1,939
-1,090
| -36% | -$357K | 0.08% | 103 |
|
|
2024
Q2 | $946K | Sell |
3,029
-188
| -6% | -$55.2K | 0.12% | 96 |
|
|
2024
Q1 | $915K | Sell |
3,217
-39
| -1% | -$11.4K | 0.11% | 97 |
|
|
2023
Q4 | $938K | Buy |
3,256
+142
| +5% | +$38.7K | 0.11% | 98 |
|
|
2023
Q3 | $837K | Buy |
3,114
+28
| +0.9% | +$6.99K | 0.1% | 106 |
|
|
2023
Q2 | $685K | Buy |
3,086
+21
| +0.7% | +$4.87K | 0.07% | 114 |
|
|
2023
Q1 | $741K | Buy |
3,065
+399
| +15% | +$97.9K | 0.08% | 110 |
|
|
2022
Q4 | $700K | Buy |
2,666
+28
| +1% | +$7.51K | 0.08% | 112 |
|
|
2022
Q3 | $595K | Hold |
2,638
| – | – | 0.07% | 116 |
|
|
2022
Q2 | $642K | Buy |
2,638
+55
| +2% | +$13.5K | 0.07% | 114 |
|
|
2022
Q1 | $625K | Buy |
2,583
+142
| +6% | +$32.6K | 0.06% | 127 |
|
|
2021
Q4 | $549K | Buy |
2,441
+197
| +9% | +$41.6K | 0.05% | 136 |
|
|
2021
Q3 | $477K | Buy |
2,244
+203
| +10% | +$46.7K | 0.05% | 134 |
|
|
2021
Q2 | $497K | Sell |
2,041
-10
| -0.5% | -$2.46K | 0.04% | 144 |
|
|
2021
Q1 | $510K | Buy |
2,051
+3
| +0.1% | +$716 | 0.04% | 141 |
|
|
2020
Q4 | $471K | Sell |
2,048
-219
| -10% | -$50.5K | 0.04% | 143 |
|
|
2020
Q3 | $576K | Sell |
2,267
-1,934
| -46% | -$479K | 0.05% | 130 |
|
|
2020
Q2 | $991K | Sell |
4,201
-1,665
| -28% | -$380K | 0.07% | 140 |
|
|
2020
Q1 | $1.19M | Buy |
5,866
+3,869
| +194% | +$845K | 0.15% | 92 |
|
|
2019
Q4 | $481K | Buy |
1,997
+74
| +4% | +$16.3K | 0.05% | 137 |
|
|
2019
Q3 | $372K | Sell |
1,923
-51
| -3% | -$9.79K | 0.05% | 131 |
|
|
2019
Q2 | $364K | Buy |
+1,974
| New | +$353K | 0.05% | 131 |
|
|
2019
Q1 | – | Sell |
-1,915
| Closed | -$373K | – | 103 |
|
|
2018
Q4 | $373K | Buy |
1,915
+341
| +22% | +$66.5K | 0.06% | 115 |
|
|
2018
Q3 | $326K | Buy |
1,574
+60
| +4% | +$11.8K | 0.04% | 137 |
|
|
2018
Q2 | $279K | Buy |
1,514
+68
| +5% | +$12K | 0.04% | 134 |
|
|
2018
Q1 | $247K | Sell |
1,446
-216
| -13% | -$39.6K | 0.04% | 141 |
|
|
2017
Q4 | $289K | Buy |
+1,662
| New | +$294K | 0.04% | 136 |
|
Other funds holding AMGN
VCM
VPM
MainStreet Investment Advisors's AMGN Position: Q1 2026 in Review
MainStreet Investment Advisors reduced its Amgen (AMGN) stake by 7.4% in Q1 2026, selling an estimated $37.1K and leaving 1,310 shares worth $461K. The position accounts for 0.07% of the portfolio, ranked #133.
MainStreet Investment Advisors first reported a position in AMGN in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.19M in Q1 2020. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- MainStreet Investment Advisors held 1,310 shares of Amgen worth $461K as of Q1 2026.
- MainStreet Investment Advisors sold 104 Amgen shares in Q1 2026, an estimated $37.1K.
- Amgen made up 0.07% of MainStreet Investment Advisors's portfolio in Q1 2026, its #133 holding.
- MainStreet Investment Advisors first reported a position in Amgen in Q4 2017 and has held it in 33 quarters since.
- MainStreet Investment Advisors's Amgen position peaked at $1.19M in Q1 2020.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on MainStreet Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.